ReviewFrontiers in oncology2021

Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice.

Ambrogio Gagliano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.